State-of-the-Art STEMI Care
Monday, April 4, 2:00-3:30 PM
In the last several years, there have been concerted efforts by many hospital systems to reduce their door-to-balloon times. This effort has paid off as more STEMI patients are being treated in the cath lab earlier than in previous years. Yet, coordinating the door-to-balloon effort is challenging and spans across many disciplines within and without the hospital system. This is one area that will be discussed in this session. Once a facility has organized its resources to reduce door-to-balloon time, it can use the same infrastructure to implement quick urgent care in other vulnerable populations, such as those needing emergent AAA care.
Once the STEMI patient is in the cath lab, there are still nuances that need to be explored in order to provide the optimal care. When should fibrinolysis be used and when should it not? Should primary PCI be the preferred treatment for all STEMI patients? What is the role of ventricular assist devices in the STEMI population?
A new paradigm being explored is using percutaneous assist devices in complex PCI cases and in PCI patients who are in shock. Preliminary data from the USpella registry is encouraging for this approach.
STEMI patients represent a significant challenge for interventional cardiologists. Time is of the essence and all the planning and protocols need to be worked out so that at the time of transport and treatment, everyone is moving smoothly and not encumbered with overthinking the process.
Speaker Information
Holger Thiele, MD, University of Leipzig Heart Center, Leipzig, Germany -- The Importance of Ischemic Time in Assessing STEMI Treatment Outcomes
James Mccarthy, MD, University of Texas, Houston -- Optimal Organization of EMS/Air Transport Protocols for STEMI Treatment
Christopher B. Granger, MD, Duke University Medical Center, Durham, N.C. -- Should Primary PCI Continue to Be the Preferred Treatment for All STEMI Patients?
Manesh R. Patel, MD, Duke University Medical Center,Durham, N.C. -- Potential Role of LV Support in Acute STEMI Treatment
Alice K. Jacobs, MD, Boston University School of Medicine, Boston -- Mission Lifeline: Are We Closing the Gap?
Alice K. Jacobs, MD, Boston University School of Medicine, Boston -- State-of-the-Art STEMI Care
Paul Wayne Armstrong, MD, University of Alberta, Edmonton, Canada -- Panelist
James C. Blankenship, MD, Geisinger Health System, Danville, Pa. -- Panelist
Timothy D. Henry, MD, Minneapolis Heart Institute, Minneapolis -- Panelist
In the last several years, there have been concerted efforts by many hospital systems to reduce their door-to-balloon times. This effort has paid off as more STEMI patients are being treated in the cath lab earlier than in previous years. Yet, coordinating the door-to-balloon effort is challenging and spans across many disciplines within and without the hospital system. This is one area that will be discussed in this session. Once a facility has organized its resources to reduce door-to-balloon time, it can use the same infrastructure to implement quick urgent care in other vulnerable populations, such as those needing emergent AAA care.
Once the STEMI patient is in the cath lab, there are still nuances that need to be explored in order to provide the optimal care. When should fibrinolysis be used and when should it not? Should primary PCI be the preferred treatment for all STEMI patients? What is the role of ventricular assist devices in the STEMI population?
A new paradigm being explored is using percutaneous assist devices in complex PCI cases and in PCI patients who are in shock. Preliminary data from the USpella registry is encouraging for this approach.
STEMI patients represent a significant challenge for interventional cardiologists. Time is of the essence and all the planning and protocols need to be worked out so that at the time of transport and treatment, everyone is moving smoothly and not encumbered with overthinking the process.
Speaker Information
Holger Thiele, MD, University of Leipzig Heart Center, Leipzig, Germany -- The Importance of Ischemic Time in Assessing STEMI Treatment Outcomes
James Mccarthy, MD, University of Texas, Houston -- Optimal Organization of EMS/Air Transport Protocols for STEMI Treatment
Christopher B. Granger, MD, Duke University Medical Center, Durham, N.C. -- Should Primary PCI Continue to Be the Preferred Treatment for All STEMI Patients?
Manesh R. Patel, MD, Duke University Medical Center,Durham, N.C. -- Potential Role of LV Support in Acute STEMI Treatment
Alice K. Jacobs, MD, Boston University School of Medicine, Boston -- Mission Lifeline: Are We Closing the Gap?
Alice K. Jacobs, MD, Boston University School of Medicine, Boston -- State-of-the-Art STEMI Care
Paul Wayne Armstrong, MD, University of Alberta, Edmonton, Canada -- Panelist
James C. Blankenship, MD, Geisinger Health System, Danville, Pa. -- Panelist
Timothy D. Henry, MD, Minneapolis Heart Institute, Minneapolis -- Panelist